When: Q3 earnings miss or guide-down >5%

Then: Maintain Underweight; reassess after 10 sessions

When: Confirmed close >$193.75 (200 SMA) on volume >3.5M AND RSI >40

Then: Tactical add of ~15% back toward 65-70% residual

When: Flush to $170-175 with RSI sub-30 bullish divergence AND 10Y rolling below 4.75%

Then: Deep-value reload to 80-85% residual with stops below $165

When: Close <$182.63 on volume

Then: Escalate: additional 15-20% trim; total residual 30-40%

When: Close <$178.50

Then: Full exit of remaining position

HOLD current position, do not add capital; stop at 182.00; shift to REDUCE if lower band at 182.63 breaks on volume

• 18% drawdown in a 0.29 beta stock is 12x the expected market move, indicating institutional distribution rather than repositioning
• Operating margins expanded from 5.2% to 11.4%, but stock rallied 46% from 155 to 226 over nine months—recovery is priced
• Trailing P/E of 32.5x and PEG of 2.15 reflect rich valuation; forward P/E of 23.5 is more reasonable but still elevated for industrials
• Iran conflict scenario at 16% Polymarket odds is public information already priced into defense multiples; 84% base case is no invasion
• Accounts receivable grew 53% against 32% revenue growth, indicating cash conversion deterioration that could surprise on Q3 earnings
• 10 EMA at 188.41 is resistance, not support, until reclaimed
• Stop at 182.00 is 1.4% below current price, under one ATR (3.61) of risk; tightening stop to 183.00 recommended if lower band at 182.63 threatens
• HOLD respects fundamentals justifying the position while refusing to add due to unfavorable technicals and risk/reward
• If lower band breaks and stop triggers, HOLD becomes reduce—protecting capital while staying positioned for future opportunity

→ vs aggressive: Using beta of 0.29 backwards—low beta makes the 18% drawdown MORE alarming as it represents ~12x expected market movement, not evidence of defensive resilience

→ vs aggressive: Margin recovery from 5.2% to 11.4% is past-tense catalyst already priced at 32.5x trailing earnings; showing up after a 46% rally complaining about missed catalysts is narrative not analysis

→ vs aggressive: Iran/Polymarket 16% odds is public information fully incorporated into 2024 defense multiples, not undiscovered alpha; the 84% base case is no invasion and geopolitical premium deflates

→ vs aggressive: Did not engage with accounts receivable growing 53% against 32% revenue—a real cash conversion deterioration that could cause free cash flow disappointment in Q3

→ vs neutral: Waiting is acceptable but must include defined triggers; if RTX closes below 182.63 on volume, neutral should shift to reduce rather than continue waiting

HOLD current position; do not add; scale in on confirmed reversal above 188.41 (10 EMA) with rising RSI in 2-3 tranches; reduce on breakdown below 182.63 (lower Bollinger band)

• The 18% drawdown in a 0.29 beta stock reflects overearning of forward expectations, not institutional distribution or accumulation
• The Iran catalyst is real but not mispriced—the 16% invasion probability and rising missile demand are publicly known and fully digested by defense ETFs
• Operating margin expansion from 5.2 to 11.4 is structural and multi-year, but largely priced into the 32.5 trailing multiple
• Receivables growing 53% against revenue growing 32% is a watch item—longer collection cycles on FMS contracts and multi-year billing milestones are plausible explanations
• Deferred revenue growth to 22.7 billion from 14.6 billion in 2022 suggests winning multi-year contracts, structurally bullish for backlog but bearish for near-term cash conversion
• Current stop at 182 (0.74 ATR) is optimal—0.46 ATR at 183 is too tight given ATR of 3.61 and lower Bollinger band at 182.63
• Q3 earnings in late October will clarify the receivables situation—HOLD provides exposure to both FCF outcomes
• The synthesis: fundamentals support holding through technical noise; technicals do not support adding at current levels

→ vs aggressive: Calling HOLD an offensive strike is misleading—defining risk with a stop and waiting for confirmation is disciplined, not aggressive; the Iran catalyst is not mispriced or underappreciated as Polymarket odds are publicly known and liquid

→ vs conservative: A stop at 183 is too tight at 0.46 ATR and will be stopped out by normal intraday volatility; the base case is rising escalation odds not falling; receivables growth may reflect FMS contract structure not channel stuffing